Back

Use of parenteral prostanoids and outcomes in older patients with pulmonary arterial hypertension

18 May 2025 (15:18 - 15:27)
Organised by: Logo
Congress Presentation Part of: Breaking the pressure: innovations in pulmonary hypertension management Pulmonary Hypertension HFA Premium Access Heart Failure 2025 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Giulio Savonitto

Karolinska Institutet, Stockholm (Italy)

4 More presentations in this session

Presentation thumbnail
Improving risk prediction in pulmonary hypertension: the role of pulmonary arterial compliance
Mr D. Inacio Cazeiro (Lisbon, PT)
Abstract Slides Video
Presentation thumbnail
TAPSE/PASP ratio: revealing the hidden predictor of pulmonary hypertension in acute pulmonary embolism
Doctor S. Esteves (Lisbon, PT)
Abstract Slides Video
Presentation thumbnail
The Failing Fontan: from the successful palliation to the unavoidable not-so-slowly progressive failure of the circuit
Doctor A. Pinho (Porto, PT)
Abstract Slides Video
Presentation thumbnail
Value of myocardial strain techniques for early diagnosis of pulmonary arterial hypertension in scleroderma patients
Doctor A. Reina (Seville, ES)
Abstract Slides Video

Access the full session

Session thumbnail
Breaking the pressure: innovations in pulmonary hypertension management
Video

The Event

Event poster

Heart Failure 2025

18 May 2025 15:18 CET
You may be interested in
thumbnail
Congress Presentation
Infl uence Of Age In The Assessment Of Therapeutic Response In Patients With Pulmonary Arterial Hypertension
thumbnail
Congress Session
Phenotyping and risk stratification in pulmonary arterial hypertension
thumbnail
Congress Presentation
Not all pulmonary arterial hypertension (PAH) patients are young women

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources